Correlación entre síndrome coronario agudo y COVID-19 en el Hospital Universitario Clínico Quirúrgico Comandante Faustino Pérez Hernández

Introducción: las infecciones agudas por SARS-CoV-2 (COVID-19) provocaron una pandemia global desde que aparecieran los primeros casos en Wuhan (China) en diciembre de 2019. Objetivo: determinar la correlación entre la infección por COVID-19 y algunas variables clínicas en la aparición del síndrome coronario agudo. Materiales y métodos: se realizó un estudio descriptivo retrospectivo en 85 pacientes que ingresaron en la Unidad de Cuidados Intensivos Emergentes del Hospital Universitario Clínico Quirúrgico Comandante Faustino Pérez Hernández, con diagnóstico de infección por COVID-19, en el período entre julio y septiembre de 2021. Durante su evolución clínica, 16 de ellos tuvieron un síndrome coronario agudo. Se aplicó el test chi cuadrado y significación estadística (p < 0,05). Resultados: el total de pacientes con síndrome coronario agudo durante la evolución de la infección por COVID-19, representó el 18,82 %. En este grupo predominaron personas de piel blanca y sexo femenino, para un 51,31 % (p < 0,02). El síndrome coronario agudo apareció después de 10 días de evolución de la infección por COVID-19, asociado a trastornos de la oxigenación. El 62,5 % de los pacientes fueron tratados con máscara con reservorio. La mayoría de los pacientes fue transferida viva a las unidades de cuidados progresivos. Conclusiones: se observó asociación estadística significativa entre féminas de raza blanca y la aparición del síndrome coronario agudo en el curso de la infección por COVID-19, en la Unidad de Cuidados Intensivos Emergentes del hospital matancero.

Introduction: acute infections by SARS-CoV-2 (COVID-19) caused a global pandemic since the first cases appeared in Wuhan (China) in December 2019. Objective: to determine the correlation between COVID-19 infection and some clinical variables at the onset of acute coronary syndrome. Materials and methods: a retrospective descriptive study was carried out in 85 patients who were admitted in the Emergent Intensive Care Unit of the Clinical Surgical University Hospital Comandante Faustino Perez Hernandez, with diagnosis of COVID-19 infection, in the period from July to September 2021. During their clinical evolution, 16 of them had acute coronary syndrome. The Chi-square test and statistical significance (p < 0.05) were applied. Results: the total of patients with acute coronary syndrome during the evolution of the COVID-19 infection represented 18.82%. White-skinned and female people predominated in this group, for 51.31% (p < 0.02). Acute coronary syndrome appeared after 10 days of the COVID-19 infection evolution, associated to oxygenation disorders. 62.5% of the patients were treated with reservoir masks. Most of the patients were transferred alive to progressive care units. Conclusions: a significant statistic association was observed between white women and the onset of acute coronary syndrome in the course of COVID-19 infection, in the Emergent Intensive Care Unit of Matanzas hospital.

Acute kidney injury in Jamaicans with sickle cell disease hospitalized with COVID-19 infection.

Despite a high occurrence of acute kidney injury (AKI) with COVID-19 infection, there are no data on its incidence in sickle cell disease (SCD). We performed a single-center retrospective chart review of persons aged >1 year with SCD, COVID-19 infection and no prior dialysis requirement hospitalized from June 1, 2020 to May 31, 2022. Demographics, clinical, laboratory characteristics and outcomes were abstracted. AKI was defined using Kidney Disease Improving Global Outcomes (KDIGO) criteria. Of 38 patients meeting study criteria (60.6% female, mean age ± SD 38.6 ± 15.9 years), 3 (7.9%) were COVID vaccinated. Fifty-five percent (55%) developed AKI with 7.9% (n = 3) requiring dialysis. Participants with AKI were older (44.9 versus 30.8 years, p = 0.005), with a higher proportion having baseline chronic kidney disease (52% versus 0%, p = 0.001). Severe COVID infection [age-adjusted odds ratio (aOR): 8.93, 95%CI: 1.73-45.99, p = 0.033], red cell transfusion (aOR 7.92, 1.47-42.69) and decrease in hemoglobin per unit from baseline (aOR 2.85, 1.24-2.28) were associated with AKI. Five persons died in hospital, with AKI resulting in higher median length of stay (12 versus 5 days, p = 0.007). Targeted COVID-19 preventative measures and multinational longitudinal studies to ascertain the impact of AKI and COVID-19 infection in SCD are needed.

Severe Adams-Oliver Syndrome after Maternal COVID-19 Infection Could Be Another Effect of the SARS-CoV-2 Inflammatory Storm? Case Report.

Background. Adams-Oliver syndrome is a congenital disease whose main findings are aplasia cutis congenita of the scalp and terminal transverse limb defects. The pathogenesis is unknown, but it is postulated that ischemic events in susceptible tissues cause the lesions in the embryonic period.Case report. We present a newborn with a severe phenotype of Adams-Oliver syndrome. The infant's mother had a SARS-CoV-2 infection in the first trimester of pregnancy. Prenatal ultrasound indicates a probable worsening of the disease after the first trimester.Conclusion. This study shows a previously unpublished severe AOS phenotype in a term newborn. There are some signs that the disease could have progressed beyond the first trimester, either spontaneously or by the inflammatory mechanisms of SARS-CoV-2.

Diagnóstico Errôneo de Angiossarcoma Cardíaco na Era COVID-19 / Misdiagnosis of a Cardiac Angiosarcoma During the COVID-19 Pandemic

Resumo Os últimos meses de 2019 foram marcados pelo surgimento de uma nova pandemia, denominada "COVID-19". Desde então, essa infecção e suas complicações têm sido a prioridade de profissionais de saúde, com muitos sintomas atribuídos às suas apresentações precoces e tardias. Até o momento, outras doenças, mesmo em situações fatais, têm sido negligenciadas ou diagnosticadas incorretamente devido à atribuição dos sintomas do paciente à presença da infecção por COVID-19. Apresentamos aqui um caso de angiossarcoma cardíaco, em um menino que, cerca de 2 meses antes, havia sido infectado com COVID-19. Dado o histórico de infecção, a abordagem inicial foi o manejo da miopericardite pós-COVID-19. No entanto, o quadro do paciente piorou, exigindo reavaliação por multimodalidades com maior precisão. Por fim, o paciente foi diagnosticado com um tumor cardíaco. Este artigo procura enfatizar a importância da atenção a outras doenças e condições fatais na era COVID-19, com ênfase em evitar diagnósticos incorretos de outras doenças.

Abstract The final months of 2019 saw the emergence of a new pandemic termed "COVID-19". Since then, this infection and its complications have been the priority of healthcare providers, with many symptoms attributed to its early and late presentations. Thus far, other diseases, even fatal situations, have been overlooked or misdiagnosed due to the attribution of patient symptoms to the presence of COVID-19 infection. We herein present a case of cardiac angiosarcoma in a young boy who had previously become infected with COVID-19 about two months earlier. Given the history of infection, the initial approach was post-COVID-19 myopericarditis management. However, the patient's condition worsened, necessitating reevaluation via multimodalities with higher precision. Ultimately, the patient was diagnosed with a cardiac tumor. This article seeks to underscore the significance of taking heed of other diseases and fatal conditions during the COVID-19 pandemic with an emphasis on avoiding misdiagnosing other diseases.

COVID-19 testing, infection, and vaccination among deported Mexican migrants: Results from a survey on the Mexico-U.S. border.

Background: Migrants detained and held in immigration and other detention settings in the U.S. have faced increased risk of COVID-19 infection, but data on this population is scarce. This study sought to estimate rates of COVID-19 testing, infection, care seeking, and vaccination among Mexican migrants detained by U.S. immigration authorities and forcibly returned to Mexico. Methods: We conducted a cross-sectional probability survey of Mexican migrants deported from the U.S. to three Mexican border cities: Tijuana, Ciudad Juárez, and Matamoros (N = 306). Deported migrants were recruited at Mexican migration facilities after being processed and cleared for departure. A two-stage sampling strategy was used. Within each city, a selection of days and shifts were selected during the operating hours of these deportation facilities. The probability of selection was proportional to the volume of migrants deported on each day of the month and during each time period. During the selected survey shifts, migrants were consecutively approached, screened for eligibility, and invited to participate in the survey. Survey measures included self-reported history of COVID-19 testing, infection, care seeking, vaccination, intentions to vaccinate, and other prevention and risk factors. Weighted data were used to estimate population-level prevalence rates. Bivariate tests and adjusted logistic regression models were estimated to identify associations between these COVID-19 outcomes and demographic, migration, and contextual factors. Results: About 84.1% of migrants were tested for COVID-19, close to a third were estimated to have been infected, and, among them, 63% had sought care for COVID-19. An estimated 70.1% had been vaccinated against COVID-19 and, among those not yet vaccinated, 32.5% intended to get vaccinated. Close to half (44.3%) of respondents had experienced crowdedness while in detention in the U.S. Socio-demographic (e.g. age, education, English fluency) and migration-related (e.g. type of detention facility and time in detention) variables were significantly associated with COVID-19 testing, infection, care seeking, and vaccination history. Age, English fluency, and length of detention were positively associated with testing and vaccination history, whereas detention in an immigration center and length of time living in the U.S. were negatively related to testing, infection, and vaccination history. Survey city and survey quarter also showed adjusted associations with testing, infection, and vaccination history, reflecting potential variations in access to services across geographic regions and over time as the pandemic unfolded. Conclusion: These findings are evidence of increased risk of COVID-19 infection, insufficient access to testing and treatment, and missed opportunities for vaccination among Mexican migrants detained in and deported from the U.S. Deportee receiving stations can be leveraged to reduce disparities in testing and vaccination for deported migrants. In addition, decarceration of migrants and other measures informed by public health principles must be implemented to reduce COVID-19 risk and increase access to prevention, diagnostic, and treatment services among this underserved population.

Observations on 73 Vaccine breakthrough COVID-19 infected patients and its individualized homeopathic treatment

Since the initiation of vaccine rollout, breakthrough COVID-19 infections have been reported. While conventional therapy is the accepted mode of treatment, there has been little recognition of the role played by the alternative therapies like homeopathy. The purposes of this study were to identify the clinico-symptomatic profile of the vaccine breakthrough covid-19 infections and to assess the response of individualized homoeopathic treatment in these breakthrough cases. A retrospective data analysis of patients treated with homoeopathic medicines who confirmed the breakthrough infection criteria: positive infection ≥14 days after completion of both the recommended doses of an authorized COVID-19 vaccine was conducted. IBM SPSS Statistics 21.0 was used for data analysis with a p-value below 0.05 defined as significant. WHO Clinical Progression Scale and Outcome in Relation to Impact on Daily Living score were used as outcome measures. In total 73 cases were reported to be vaccine breakthrough infections. The median recovery time reported in the data set was 9 ± 2 days. While 5 patients dropped out, 68 (93.15%) patients responded positively to homeopathic treatment, and 55 (75.34%) recovered completely with normalized serological markers/ nasal swabs/ HRCT Chest. About 29 (39.72%) of these presented with mild clinical manifestations, 26 (35.61%) moderate, 17 (23.28%) severe and 1 (1.36%) was critical. 10 homeopathic remedies were prescribed to these 73 patients. Majority of the patients attained an ORIDL score of 4. Maximum patients reported a WHO clinical Progression score of 3. Statistical analysis showed a significant response to homeopathic treatment in the study group. Vaccine breakthrough cases occur in a fraction of vaccinated people. Despite the limited number of study subjects, homoeopathy showed some promising results in the present setup. The response rate was highest in the moderate and severe cases which suggest the importance of consideration of alternative medicine in the current pandemic. Further exploratory research studies and comparative clinical trials may be encouraged.

COVID-19 Infection in Octagenarian Patients: Imaging Aspects and Clinical Correlations.

INTRODUCTION: Computed tomography (CT) of the chest, although not a screening test or diagnosis of infection with the new coronavirus, has a fundamental role in assessing the extent of lung involvement and complications such as pleural effusion. Considering the higher morbidity and mortality of elderly patients due to this infection, the objective of this study was to evaluate the imaging aspects and clinical correlations of an extreme age (≥80 years) with a confirmed diagnosis for COVID-19. METHODS: This was a retrospective and single-center cohort study. CT scans were categorized qualitatively and quantitatively. In the first case, 3 descriptors were used to describe CT findings: "compatible" (findings of greater specificity for COVID-19: opacities with attenuation in ground glass with peripheral and bilateral distribution, with rounded morphology, with or without consolidations, crazy-pavement aspect, inverted halo sign, or organizing pneumonia findings), "doubtful" (findings not specific or unusual for COVID-19: opacities with attenuation in ground glass with nonrounded morphology, central, diffuse, or unilateral distribution, with or without consolidation, lobar or segmental consolidation without ground-glass opacity, small centrilobular nodules with the appearance of "tree-in-bud," excavations, pleural effusion, and thickening of interlobular septa), and "negative" (absence of pneumonia signs). For the quantitative assessment, which referred to the extent of pulmonary involvement, a tomographic severity classification was used: grade 1 (lung involvement ≤25%), grade 2 (pulmonary involvement between 26 and 50%), and grade 3 (pulmonary involvement >50%). RESULTS: A total of 138 patients were evaluated, with an average age of 86.2 years (84 women and 34 men). The mean time interval between onset of symptoms and tomography was 5.63 days. The most prevalent comorbidity was systemic arterial hypertension (81.2%). Compatible, doubtful, and negative tests were 117 (84.7%), 20 (14.4%), and 1 (0.7%), respectively. As for compatible exams, the most common findings were opacities in peripheral ground glass and rounded morphology, followed by crazy paving. The prevalence of pleural effusion was 28.2% and consolidation was 63.7%, and none of these findings were influenced by the duration of symptoms (p = 0.08 and p = 0.2, respectively). The exams classified as grade 1, grade 2, and grade 3 were 57 (41.6%), 46 (33.6%), and 34 (24.8%), respectively. There were statistically significant associations between the classification of tomographic severity and outcomes such as invasive ventilation (p = 0.004), admission to the intensive care unit (p < 0.001), and death (p < 0.001). DISCUSSION/CONCLUSION: Our results show that patients ≥80 years old present tomographic manifestations similar to those described for the general population (ground-glass opacities and "crazy paving") and that the extent of lung involvement is associated with the need for intensive care, invasive ventilation, and death. Although the literature describes an association between the stage of the disease and the appearance of consolidations and pleural effusion, this correlation was not observed in our study, which may suggest that this age-group is more predisposed to the appearance of such findings, typically described in the more advanced stages of infection.

COVID-19 Infection and Neuropathological Features.

The pathology associated with COVID-19 infection is progressively being revealed. Recent postmortem assessments have revealed acute airway inflammation as well as diffuse alveolar damage, which bears resemblance to severe acute respiratory syndromes induced by both SARS-CoV and MERS-CoV infections. Although recent papers have highlighted some neuropathologies associated with COVID-19 infection, little is known about this topic of great importance in the area of public health. Here, we discuss how neuroinflammation related to COVID-19 could be triggered by direct viral neuroinvasion and/or cytokine release over the course of the infection.

Acute right ventricular failure in COVID-19 infection: A case series.

Severe forms of COVID-19 infection are associated with the need for invasive mechanical ventilation and thromboembolic complications; those can affect the cardiac function especially the right ventricle performance. Critical care echocardiography has rapidly evolved as the election technique in the evaluation of the critically ill patients. This technique has the advantage that it can be done at patient´s bedside and helps to provide the appropriate treatment and to monitoring maneuver's response. We present 4 patients with a confirmed COVID-19 infection who presented with sudden hemodynamic and / or respiratory deterioration, in which transthoracic echocardiogram showed acute right ventricular failure as the trigger for the event and helped to guide an early therapeutic intervention. .

Cuidados críticos en neumonía por virus SARS-CoV-2 durante el embarazo. Reporte de un caso / Critical care in SARS-CoV-2 virus pneumonia during pregnancy. Report a case

Resumen ANTECEDENTES: La pandemia mundial de SARS-CoV-2 también afecta a las embarazadas. Los casos más graves ameritan hospitalización y tratamiento en una sala de cuidados intensivos. CASO CLÍNICO: Paciente de 30 años y embarazo con feto único, de 33 semanas, con antecedentes de fibromialgia, un aborto y miomatosis uterina. La paciente negó el contacto con personas sospechosas o infectadas por el virus SARS-CoV-2. El cuadro clínico se inició con infección de las vías respiratorias superiores que evolucionó a neumonía con prueba PCR positiva para COVID-19 a partir del exudado naso-faríngeo, que condicionó el síndrome de insuficiencia respiratoria aguda severa, tratada con asistencia mecánica ventilatoria durante16 días en la unidad de cuidados intensivos. En el trascurso de la hospitalización se complicó con neumotórax bilateral y urosepsis por Candida tropicalis. La paciente superó la enfermedad viral, las complicaciones de la ventilación y la infección urinaria oportunista.

Abstract BACKGROUND: The worldwide SARS-CoV-2 pandemic also affects pregnant women. The most severe cases require hospitalization and treatment in an intensive care unit. CLINICAL CASE: A 30-year-old woman with a 33-week singleton pregnancy and a history of fibromyalgia, one miscarriage and uterine myomatosis. The patient denied contact with persons suspected or infected with SARS-CoV-2 virus. The clinical picture began with upper respiratory tract infection that progressed to pneumonia with positive PCR test for COVID-19 from nasopharyngeal exudate, which led to severe acute respiratory failure syndrome, treated with mechanical ventilation for 16 days in the Intensive Care Unit. During hospitalization, she was complicated with bilateral pneumothorax and urosepsis due to Candida tropicalis. The patient overcame the viral disease, ventilatory complications and the opportunistic urinary tract infection.

Factors related to asymptomatic or severe COVID-19 infection.

The factors that may contribute to a COVID-19 patient remaining in the asymptomatic stage, or to the infection evolving into the more serious stages are examined. In particular, we refer to the TMPRSS2 expression profile, balance of androgen and estrogen, blood group-A and/or B, nonsynonymous mutations in ORF3, and proteins NS7b and NS8 in SARS-CoV-2. Also, we review other factors related to the susceptibility and pathogenicity of SARS-CoV-2.

Benford´s Law with small sample sizes: A new exact test useful in health sciences during epidemics / Ley de Benford con muestras pequeñas: una prueba exacta nueva útil ciencias de la salud durante epidemias

Abstract Benford or "first digit" law has been used successfully to evaluate epidemiological surveillance systems, especially during epidemics. Conventional statistical methods for evaluation (x2 and log-likelihood ratio) are controversial when the number of data is small (n <7). In this methodological note a new test is proposed to evaluate compliance with Benford's law with small samples, which can be used with biomedical, medical and public health data.

Resumen La ley de Benford o de los "primeros dígitos" ha sido usada exitosamente para evaluar los sistemas de vigilancia epidemiológica, en especial durante epidemias. Los métodos estadísticos convencionales para la evaluación (x 2 y razón de log-verosimilitud) son controversiales cuando los datos son poco (n<7). En esta nota metodológica se propone una nueva prueba para evaluar el cumplimiento de la ley de Benford con muestras pequeñas, que puede ser usada con datos de biomedicina, medicina y salud pública.

Expert recommendations for the care of newborns of mothers with COVID-19

This article presents expert recommendations for assisting newborn children of mothers with suspected or diagnosed coronavirus disease 2019 </mac_aq>(COVID-19). The consensus was developed by five experts with an average of 20 years of experience in neonatal intensive care working at a reference university hospital in Brazil for the care of pregnant women and newborns with suspected or confirmed COVID-19. Despite the lack of scientific evidence regarding the potential for viral transmission to their fetus in pregnant mothers diagnosed with or suspected of COVID-19, it is important to elaborate the lines of care by specialists from hospitals caring for suspected and confirmed COVID-19 cases to guide multidisciplinary teams and families diagnosed with the disease or involved in the care of pregnant women and newborns in this context. Multidisciplinary teams must be attentive to the signs and symptoms of COVID-19 so that decision-making is oriented and assertive for the management of the mother and newborn in both the hospital setting and at hospital discharge.